SERPINA7 and hepatocellular carcinoma: In our study, we designed a liver-specific promoter (LSP) that achieved higher transgene expression efficiency compared with TBG and hAAT, with no evidence of hepatotoxicity or HCC in treated mice (Fig. S11).